Clinical Trial

Caris Biorepository Research Protocol

Recruiting
View on ClinicalTrials.gov →
Summary
The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients. The Caris Biorepository is a repository of prospectively collected biological specimens and associated clinical and demographic data gathered from multiple sources to be stored, used and shared for research. Caris Life Sciences will maintain the data and specimens and will control access to and use of the information and specimens by multiple individuals for multiple purposes which may evolve over time.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2011-12-22; most recent amendment 2026-01-19.
Status change: Active, Not Recruiting → Recruiting 2020-01-21
Status change: Recruiting → Active, Not Recruiting 2015-05-18
Trial Details
NCT Number NCT01499394
Lead Sponsor Caris Science, Inc.
Conditions Cancer, Early Detection of Cancer, Minimal Residual Disease
Enrollment 100,000 participants
Start Date 2010-11
Primary Completion 2030-11 (estimated)
Study Completion 2035-11 (estimated)
Updated on ClinicalTrials.gov 2026-01-21